Inspire Medical Systems operates in the medical technology sector, specializing in innovative, minimally invasive solutions for patients grappling with a common nocturnal affliction where breathing repeatedly stops and starts. For those who find traditional mask-based therapies akin to sleeping with a vacuum cleaner attached to their face – a truly inspiring thought – the company offers a sophisticated alternative. Its flagship product, the Inspire therapy system, is an implantable neurostimulation device designed to keep airways open during slumber. This ingenious system comprises an internal pulse generator, sensing and stimulation leads, a patient-controlled remote, and clinician programming tools, all working in concert to ensure a less interrupted night.

The company’s business model is that of a "category builder" within the therapeutic devices industry, focusing on establishing a comprehensive treatment pathway rather than merely selling hardware. This involves extensive direct sales to hospitals and ambulatory surgery centers, alongside efforts to expand payer coverage, train medical professionals, and generate patient demand through direct-to-consumer marketing. Headquartered in Golden Valley, Minnesota, Inspire primarily operates in the United States, its dominant market, with a burgeoning presence in select European countries and Japan.

A significant competitive advantage stems from its status as the first and, for a time, only FDA-approved neurostimulation technology for moderate to severe cases of this sleep disorder, boasting high patient compliance rates compared to conventional treatments. However, even pioneers face turbulence. The company has recently navigated the murky waters of patent infringement lawsuits, both as plaintiff and defendant, against competitors like Nyxoah, proving that even in the pursuit of peaceful sleep, legal battles rage on. Furthermore, it has faced scrutiny from a Department of Justice civil investigation concerning alleged false claims and grappled with reimbursement complexities and even product liability investigations related to device malfunctions, reminding everyone that even the most advanced tech can have its quirks.